Insiders · Profile

Pinion John Richard

See Remarks at Ultragenyx Pharmaceutical. Filing since 12 Oct 2020. CIK 0001648096

Company
Date
Role
Action
Shares
Amount
Of holding
2 Mar 2026
See Remarks
Sold at will
10,029
$228.66K
8.4%
3 Mar 2025
See Remarks
Sold at will
14,439
$607.88K
11.8%
1 Mar 2024
See Remarks
Sold at will
4,173
$224.34K
4.5%
18 May 2023
See Remarks
Sold at will
2,012
$100.60K
2.6%
1 Mar 2023
See Remarks
Sold, plan not stated
3,755
$169.95K
4.5%
1 Mar 2022
See Remarks
Sold, plan not stated
4,498
$299.66K
9.0%
14 Oct 2021
See Remarks
Sold, plan not stated
358
$29.05K
0.7%
6 May 2021
See Remarks
Sold, plan not stated
363
$41.27K
0.7%
1 Mar 2021
See Remarks
Sold, plan not stated
6,198
$856.38K
11.0%
14 Oct 2020
See Remarks
Sold, plan not stated
262
$23.06K
0.6%
12 Oct 2020
See Remarks
Sold, plan not stated
2,780
$262.63K
5.6%
11 decisions on file.